WAVE Life Sciences Ltd
NASDAQ:WVE
WAVE Life Sciences Ltd
Cash from Financing Activities
WAVE Life Sciences Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cash from Financing Activities
$132.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cash from Financing Activities
-S$79.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cash from Financing Activities
-S$17.3m
|
CAGR 3-Years
-114%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
I
|
IX Biopharma Ltd
SGX:42C
|
Cash from Financing Activities
S$736k
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WAVE Life Sciences Ltd's Cash from Financing Activities?
Cash from Financing Activities
132.5m
USD
Based on the financial report for Dec 31, 2023, WAVE Life Sciences Ltd's Cash from Financing Activities amounts to 132.5m USD.
What is WAVE Life Sciences Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
15%
Over the last year, the Cash from Financing Activities growth was 97%. The average annual Cash from Financing Activities growth rates for WAVE Life Sciences Ltd have been -5% over the past three years , 15% over the past five years .